212 related articles for article (PubMed ID: 20180533)
21. An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity.
Ieda N; Itoh K; Inoue Y; Izumiya Y; Kawaguchi M; Miyata N; Nakagawa H
Bioorg Med Chem Lett; 2019 Feb; 29(3):353-356. PubMed ID: 30585173
[TBL] [Abstract][Full Text] [Related]
22. A phosphorylated prodrug for the inhibition of Pin1.
Zhao S; Etzkorn FA
Bioorg Med Chem Lett; 2007 Dec; 17(23):6615-8. PubMed ID: 17935986
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors.
Zhu L; Jin J; Liu C; Zhang C; Sun Y; Guo Y; Fu D; Chen X; Xu B
Bioorg Med Chem; 2011 May; 19(9):2797-807. PubMed ID: 21504850
[TBL] [Abstract][Full Text] [Related]
24. Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1.
Tatara Y; Lin YC; Bamba Y; Mori T; Uchida T
Biochem Biophys Res Commun; 2009 Jul; 384(3):394-8. PubMed ID: 19422802
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
[TBL] [Abstract][Full Text] [Related]
26. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation.
Uchida T; Takamiya M; Takahashi M; Miyashita H; Ikeda H; Terada T; Matsuo Y; Shirouzu M; Yokoyama S; Fujimori F; Hunter T
Chem Biol; 2003 Jan; 10(1):15-24. PubMed ID: 12573694
[TBL] [Abstract][Full Text] [Related]
27. Convergent synthesis of alpha-ketoamide inhibitors of Pin1.
Xu GG; Etzkorn FA
Org Lett; 2010 Feb; 12(4):696-9. PubMed ID: 20102178
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and Pin1 inhibitory activity of thiazole derivatives.
Zhao H; Cui G; Jin J; Chen X; Xu B
Bioorg Med Chem; 2016 Nov; 24(22):5911-5920. PubMed ID: 27692510
[TBL] [Abstract][Full Text] [Related]
29. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
30. Functional conservation of phosphorylation-specific prolyl isomerases in plants.
Yao JL; Kops O; Lu PJ; Lu KP
J Biol Chem; 2001 Apr; 276(17):13517-23. PubMed ID: 11118438
[TBL] [Abstract][Full Text] [Related]
31. Peptidyl-prolyl cis/trans-isomerase A1 (Pin1) is a target for modification by lipid electrophiles.
Aluise CD; Rose K; Boiani M; Reyzer ML; Manna JD; Tallman K; Porter NA; Marnett LJ
Chem Res Toxicol; 2013 Feb; 26(2):270-9. PubMed ID: 23231502
[TBL] [Abstract][Full Text] [Related]
32. Multisite phosphorylation of Pin1-associated mitotic phosphoproteins revealed by monoclonal antibodies MPM-2 and CC-3.
Albert AL; Lavoie SB; Vincent M
BMC Cell Biol; 2004 Jun; 5():22. PubMed ID: 15171797
[TBL] [Abstract][Full Text] [Related]
33. Thermodynamics of phosphopeptide binding to the human peptidyl prolyl cis/trans isomerase Pin1.
Daum S; Fanghänel J; Wildemann D; Schiene-Fischer C
Biochemistry; 2006 Oct; 45(39):12125-35. PubMed ID: 17002312
[TBL] [Abstract][Full Text] [Related]
34. Recent advances of Pin1 inhibitors as potential anticancer agents.
Bai Y; Yuan Z; Yuan S; He Z
Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131
[TBL] [Abstract][Full Text] [Related]
35. On the benefit of bivalency in peptide ligand/pin1 interactions.
Daum S; Lücke C; Wildemann D; Schiene-Fischer C
J Mol Biol; 2007 Nov; 374(1):147-61. PubMed ID: 17931657
[TBL] [Abstract][Full Text] [Related]
36. Pin1 inhibitors: Pitfalls, progress and cellular pharmacology.
Moore JD; Potter A
Bioorg Med Chem Lett; 2013 Aug; 23(15):4283-91. PubMed ID: 23796453
[TBL] [Abstract][Full Text] [Related]
37. Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation.
Siepe D; Jentsch S
Nat Cell Biol; 2009 Aug; 11(8):967-72. PubMed ID: 19597489
[TBL] [Abstract][Full Text] [Related]
38. An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors.
Wildemann D; Hernandez Alvarez B; Stoller G; Zhou XZ; Lu KP; Erdmann F; Ferrari D; Fischer G
Biol Chem; 2007 Oct; 388(10):1103-11. PubMed ID: 17937625
[TBL] [Abstract][Full Text] [Related]
39. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer.
Finn G; Lu KP
Curr Cancer Drug Targets; 2008 May; 8(3):223-9. PubMed ID: 18473735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]